Cell-mediated immune response to beta casein in recent-onset insulin-dependent diabetes: implications for disease

M G Cavallo1, D Fava, L Monetini

  • 1Cattedra di Endocrinologia (I), Policlinico Umberto I, University of Rome, La Sapienza.

Lancet (London, England)
|October 5, 1996
PubMed

Insights

Early cow's milk consumption may trigger an immune response linked to insulin-dependent diabetes (IDDM). Researchers found specific T-lymphocyte reactions to beta-casein in IDDM patients, suggesting a cross-reaction with pancreatic beta-cells.

Area of Science:

  • Immunology
  • Endocrinology
  • Diabetes Research

Background:

  • The cows' milk hypothesis suggests early cow's milk intake may trigger autoimmune responses leading to insulin-dependent diabetes (IDDM).
  • This hypothesis is based on potential immunological cross-reactivity between cow's milk proteins and pancreatic beta-cell antigens.

Purpose of the Study:

  • To investigate the association between cow's milk protein exposure and the immune response in patients with recent-onset IDDM.
  • To determine if the immune response to cow's milk protein is specific to IDDM.

Main Methods:

  • Measured in-vitro peripheral lymphocyte response to beta-casein in 47 IDDM patients, 36 healthy controls, and 10 patients with autoimmune thyroid disease.
  • Tested responses to other antigens including bovine serum albumin, purified protein derivative, human serum albumin, and phytohaemagglutinin for specificity.

Main Results:

  • Significantly higher T-lymphocyte proliferation to beta-casein was observed in IDDM patients compared to healthy individuals (p < 0.00001) and thyroid disease patients (p < 0.002).
  • 51.1% of IDDM patients showed a positive response to beta-casein, versus 2.7% of healthy individuals and 0% of thyroid disease patients (p < 0.00001).
  • No significant differences in lymphocyte response were found for other tested antigens between groups.

Conclusions:

  • The findings support the cows' milk hypothesis by demonstrating a specific immune response to beta-casein in IDDM patients.
  • This cellular and humoral anti-beta-casein immune response may cross-react with pancreatic beta-cell antigens, potentially contributing to IDDM development.
  • Observed sequence homologies between beta-casein and beta-cell molecules warrant further investigation into the mechanism of cross-reactivity.
Abstract

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.